Previous Article | Next Article ![]()
Molecular and Cellular Biology, March 1999, p. 2373-2379, Vol. 19, No. 3
Department of Molecular Pharmacology,
Stanford University School of Medicine, Stanford, California
94305-53321; Ontario Cancer Institute
and Department of Medical Biophysics, University of Toronto, Toronto,
Ontario, M5G-2M9, Canada2; and
Center for Radiological Research, Columbia University, New
York, New York 100323
Received 2 November 1998/Accepted 9 December 1998
Life span determination in normal human cells may be regulated by
nucleoprotein structures called telomeres, the physical ends of
eukaryotic chromosomes. Telomeres have been shown to be essential for
chromosome stability and function and to shorten with each cell
division in normal human cells in culture and with age in vivo.
Reversal of telomere shortening by the forced expression of telomerase
in normal cells has been shown to elongate telomeres and extend the
replicative life span (H. Vaziri and S. Benchimol, Curr. Biol.
8:279-282, 1998; A. G. Bodnar et al., Science
279:349-352, 1998). Extension of the life span as a consequence of the
functional inactivation of p53 is frequently associated with loss of
genomic stability. Analysis of telomerase-induced
extended-life-span fibroblast (TIELF) cells by G banding and spectral
karyotyping indicated that forced extension of the life span by
telomerase led to the transient formation of aberrant structures, which
were subsequently resolved in higher passages. However, the
p53-dependent G1 checkpoint was intact as assessed by
functional activation of p53 protein in response to ionizing radiation
and subsequent p53-mediated induction of p21Waf1/Cip1/Sdi1.
TIELF cells were not tumorigenic and had a normal DNA strand break
rejoining activity and normal radiosensitivity in response to ionizing radiation.
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Analysis of Genomic Integrity and p53-Dependent G1
Checkpoint in Telomerase-Induced Extended-Life-Span Human
Fibroblasts
*
Corresponding author. Mailing address: Stanford
University School of Medicine, Department of Molecular Pharmacology,
Edward's Building, 300 Pasteur Dr., Stanford, CA 94305-5332. Phone: (650) 498-4398. Fax: (650) 725-2952. E-mail:
vaziri{at}cmgm.stanford.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|